Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

HWU, PATRICK

One or more keywords matched the following items that are connected to HWU, PATRICK

Item Type	Name
Academic Article	A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma.
Academic Article	Combined-modality therapy for patients with regional nodal metastases from melanoma.
Academic Article	Biochemotherapy in patients with advanced head and neck mucosal melanoma.
Academic Article	GPNMB expression in uveal melanoma: a potential for targeted therapy.
Academic Article	Pelvic computed tomography scans for surveillance in patients with primary melanoma in the head and neck.
Academic Article	Lovastatin inhibits T-cell proliferation while preserving the cytolytic function of EBV, CMV, and MART-1-specific CTLs.
Academic Article	Changes in pERK1/2 and pAKT expression in melanoma lesions after imatinib treatment.
Concept	Melanoma
Concept	Melanoma, Experimental
Academic Article	Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice.
Academic Article	IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity.
Academic Article	Characterization of human tumor cell lines transduced with the cDNA encoding either tumor necrosis factor alpha (TNF-a) or interleukin-2 (IL-2).
Academic Article	Correlates of response to IL-2 therapy in patients treated for metastatic renal cancer and melanoma.
Academic Article	A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma.
Academic Article	Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma.
Academic Article	A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.
Academic Article	Immunosuppression in melanoma immunotherapy: potential opportunities for intervention.
Academic Article	Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectors.
Academic Article	Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors.
Academic Article	Phase I safety study of lenalidomide and dacarbazine in patients with metastatic melanoma previously untreated with systemic chemotherapy.
Academic Article	Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma.
Academic Article	A phase II study of gefitinib in patients with metastatic melanoma.
Academic Article	Phase I study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma.
Academic Article	Comparison of two dosing schedules of palonosetron for the prevention of nausea and vomiting due to interleukin-2-based biochemotherapy.
Academic Article	Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients.
Academic Article	BRAF inhibition increases tumor infiltration by T cells and enhances the antitumor activity of adoptive immunotherapy in mice.
Academic Article	BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma.
Academic Article	The development of gene therapy for the treatment of cancer.
Academic Article	Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.
Academic Article	Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b.
Academic Article	Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine.
Academic Article	Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors.
Academic Article	Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanoma.
Academic Article	Dendritic cells strongly boost the antitumor activity of adoptively transferred T cells in vivo.
Academic Article	Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes.
Academic Article	Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma.
Academic Article	A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
Academic Article	Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates.
Academic Article	T helper 17 cells promote cytotoxic T cell activation in tumor immunity.
Academic Article	TGF-beta1 induces preferential rapid expansion and persistence of tumor antigen-specific CD8+ T cells for adoptive immunotherapy.
Academic Article	Prognostic factors for survival in melanoma patients with brain metastases.
Academic Article	Pharmacokinetics and safety of Marqibo (vincristine sulfate liposomes injection) in cancer patients with impaired liver function.
Academic Article	Immunotherapy of melanoma: an update.
Academic Article	Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
Academic Article	White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy.
Academic Article	Induction of TLR4-dependent CD8+ T cell immunity by murine ?-defensin2 fusion protein vaccines.
Academic Article	Costimulation through the CD137/4-1BB pathway protects human melanoma tumor-infiltrating lymphocytes from activation-induced cell death and enhances antitumor effector function.
Academic Article	Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy.
Academic Article	Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapy.
Academic Article	BRAF(V600) inhibitor GSK2118436 targeted inhibition of mutant BRAF in cancer patients does not impair overall immune competency.
Academic Article	Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
Academic Article	BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma.
Academic Article	Broad cross-presentation of the hematopoietically derived PR1 antigen on solid tumors leads to susceptibility to PR1-targeted immunotherapy.
Academic Article	Phase II study of the MEK1/MEK2 inhibitor Trametinib in patients with metastatic BRAF-mutant cutaneous melanoma previously treated with or without a BRAF inhibitor.
Academic Article	Persistent antigen at vaccination sites induces tumor-specific CD8? T cell sequestration, dysfunction and deletion.
Academic Article	Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes.
Academic Article	Chemical castration of melanoma patients does not increase the frequency of tumor-specific CD4 and CD8 T cells after peptide vaccination.
Academic Article	Retroviral transduction of human dendritic cells with a tumor-associated antigen gene.
Academic Article	CD40 ligand and lipopolysaccharide enhance the in vitro generation of melanoma-reactive T-cells.
Academic Article	CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
Academic Article	Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen.
Academic Article	Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma.
Academic Article	Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis.
Academic Article	Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma.
Academic Article	A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanoma.
Academic Article	Phase I/II study of a cisplatin-taxol-dacarbazine regimen in metastatic melanoma.
Academic Article	Treating cancer by targeting the immune system.
Academic Article	Transduction of tumor-specific T cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses.
Academic Article	Melanoma cells express ICOS ligand to promote the activation and expansion of T-regulatory cells.
Academic Article	Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival?
Academic Article	gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.
Academic Article	Correlation of NRAS mutations with clinical response to high-dose IL-2 in patients with advanced melanoma.
Academic Article	Detection and characterization of a novel subset of CD8?CD57? T cells in metastatic melanoma with an incompletely differentiated phenotype.
Academic Article	Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivo.
Academic Article	Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook.
Academic Article	Advances in the treatment of metastatic melanoma: adoptive T-cell therapy.
Academic Article	Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases.
Academic Article	A new approach to simultaneously quantify both TCR a- and ?-chain diversity after adoptive immunotherapy.
Academic Article	Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma.
Academic Article	Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2.
Academic Article	Differential expression of the G-protein-coupled formyl Peptide receptor in melanoma associates with aggressive phenotype.
Academic Article	Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy.
Academic Article	Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma.
Academic Article	Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens.
Academic Article	Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma.
Academic Article	Mobilization of dendritic cell precursors in patients with cancer by flt3 ligand allows the generation of higher yields of cultured dendritic cells.
Academic Article	Expression of a "self-"antigen by human tumor cells enhances tumor antigen-specific CD4(+) T-cell function.
Academic Article	Immunization of patients with metastatic melanoma using both class I- and class II-restricted peptides from melanoma-associated antigens.
Academic Article	A novel strategy for rapid and efficient isolation of human tumor-specific CD4(+) and CD8(+) T-cell clones.
Academic Article	Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.
Academic Article	Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib.
Academic Article	Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients.
Academic Article	MART-1-specific melanoma tumor-infiltrating lymphocytes maintaining CD28 expression have improved survival and expansion capability following antigenic restimulation in vitro.
Academic Article	The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanoma.
Academic Article	Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanoma.
Academic Article	In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-alpha is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII).
Academic Article	Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity.
Academic Article	Expansion and characterization of T cells transduced with a chimeric receptor against ovarian cancer.
Academic Article	Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.
Academic Article	In vivo antitumor activity of interleukin 21 mediated by natural killer cells.
Academic Article	Innovations and challenges in melanoma: summary statement from the first Cambridge conference.
Academic Article	NRAS mutation status is an independent prognostic factor in metastatic melanoma.
Academic Article	IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients.
Academic Article	Pathways and therapeutic targets in melanoma.
Academic Article	Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-a in patients with metastatic melanoma.
Academic Article	Tumor-infiltrating lymphocyte therapy for melanoma: rationale and issues for further clinical development.
Academic Article	Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma.
Academic Article	Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB/C melanoma patients with BRAFV600 mutations.
Academic Article	Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.
Academic Article	Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with advanced melanoma.
Academic Article	Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanoma.
Academic Article	Manipulating the tumor microenvironment ex vivo for enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy.
Academic Article	Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis.
Academic Article	BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma.
Academic Article	Next generation sequencing of exceptional responders with BRAF-mutant melanoma: implications for sensitivity and resistance.
Academic Article	Long-term outcome in BRAF(V600E) melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression.
Academic Article	Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report.
Academic Article	Novel Treatments in Development for Melanoma.
Academic Article	STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
Academic Article	Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.
Academic Article	Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon-V600 mutations in cutaneous melanoma patients.
Academic Article	Whole-brain radiation therapy in melanoma
Academic Article	Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma
Academic Article	Forging a link between oncogenic signaling and immunosuppression in melanoma
Academic Article	Promising results from Phase III clinical trial of a peptide vaccine for advanced melanoma
Academic Article	Synthetic Poly(L-Glutamic Acid)-conjugated CpG Exhibits Antitumor Efficacy With Increased Retention in Tumor and Draining Lymph Nodes After Intratumoral Injection in a Mouse Model of Melanoma
Academic Article	IL-2 therapy promotes suppressive ICOS⁺ Treg expansion in melanoma patients
Academic Article	Defective STAT1 activation associated with impaired IFN-Î· production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2
Academic Article	Hypoxia-driven mechanism of vemurafenib resistance in melanoma
Academic Article	Synthetic Poly(L-Glutamic Acid)-conjugated CpG Exhibits Antitumor Efficacy with Increased Retention in Tumor and Draining Lymph Nodes after Intratumoral Injection in a Mouse Model of Melanoma
Academic Article	Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma
Academic Article	A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma
Academic Article	Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn's disease
Academic Article	BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties
Academic Article	BRAF^V600E co-opts a conserved MHC class I internalization pathway to diminish antigen presentation and CD8⁺ T-cell recognition of melanoma
Academic Article	Clinicopathological features and clinical outcomes associated with TP53 and BRAF^N ^on- ^V ⁶⁰⁰ mutations in cutaneous melanoma patients
Academic Article	The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy.
Academic Article	Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain.
Academic Article	The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression.
Academic Article	HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes.
Academic Article	Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.
Academic Article	Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy.
Academic Article	Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.
Academic Article	Forging a link between oncogenic signaling and immunosuppression in melanoma.
Academic Article	BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties.
Academic Article	GNA11 Mutation in a Patient With Cutaneous Origin Melanoma: A Case Report.
Academic Article	Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade.
Academic Article	Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma.
Academic Article	Distinct clinical patterns and immune infiltrates are observed at time of progression on targeted therapy versus immune checkpoint blockade for melanoma.
Academic Article	Defective STAT1 activation associated with impaired IFN-? production in NK and T lymphocytes from metastatic melanoma patients treated with IL-2.
Academic Article	Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib Combination Treatment for BRAF Inhibitor-Refractory Metastatic Melanoma: A Phase 2 Clinical Trial.
Academic Article	Selective inhibition of autoimmune exacerbation while preserving the anti-tumor clinical benefit using IL-6 blockade in a patient with advanced melanoma and Crohn's disease: a case report.
Academic Article	Loss of IFN-? Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.
Academic Article	Metastatic Melanoma Patient Had a Complete Response with Clonal Expansion after Whole Brain Radiation and PD-1 Blockade.
Academic Article	CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner.
Academic Article	IL2 Variant Circumvents ICOS+ Regulatory T-cell Expansion and Promotes NK Cell Activation.
Academic Article	Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set.
Academic Article	A phase I study of TPI 287 in combination with temozolomide for patients with metastatic melanoma.
Academic Article	Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells.
Academic Article	Synthetic Poly(L-Glutamic Acid)-conjugated CpG Exhibits Antitumor Efficacy With Increased Retention in Tumor and Draining Lymph Nodes After Intratumoral Injection in a Mouse Model of Melanoma.
Academic Article	Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma.
Academic Article	Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.
Academic Article	A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma.
Academic Article	Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study.
Academic Article	Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control.
Academic Article	SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity.
Academic Article	Multifaceted Role of BTLA in the Control of CD8+ T-cell Fate after Antigen Encounter.
Academic Article	Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.
Academic Article	Retrospective review of metastatic melanoma patients with leptomeningeal disease treated with intrathecal interleukin-2.
Academic Article	Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome.
Academic Article	Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
Academic Article	Phase I/II Study of Hepatic Arterial Infusion of Nab-paclitaxel in Patients With Metastatic Melanoma to the Liver.
Academic Article	Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma.
Academic Article	Association between melanoma and renal-cell carcinoma for sequential diagnoses: A single-center retrospective study.
Academic Article	A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade.
Academic Article	Adjuvant Ipilimumab in High-Risk Uveal Melanoma.
Academic Article	Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Academic Article	Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Academic Article	Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma.
Academic Article	Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases.
Academic Article	IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy.
Concept	Melanoma-Specific Antigens
Concept	gp100 Melanoma Antigen
Academic Article	Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients.
Academic Article	Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3K? Inhibition in PTEN Loss Melanoma.
Academic Article	Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma.
Academic Article	B cells and tertiary lymphoid structures promote immunotherapy response.
Academic Article	Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy.
Academic Article	Cumulative Incidence and Predictors of CNS Metastasis for Patients With American Joint Committee on Cancer 8th Edition Stage III Melanoma.
Academic Article	Circulating Tumor Cells and Early Relapse in Node-positive Melanoma.
Academic Article	Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma.
Academic Article	Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02).
Academic Article	Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy).
Academic Article	Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity.
Academic Article	Nivolumab and Ipilimumab in Metastatic Uveal Melanoma: Results From a Single-Arm Phase II Study.
Academic Article	Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy.
Academic Article	Influence of injection technique, drug formulation and tumor microenvironment on intratumoral immunotherapy delivery and efficacy.
Academic Article	Tilsotolimod with Ipilimumab Drives Tumor Responses in Anti-PD-1 Refractory Melanoma.
Academic Article	IL-1a Mediates Innate and Acquired Resistance to Immunotherapy in Melanoma.
Academic Article	Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma.
Academic Article	Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy).
Academic Article	Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 3rd-5th, 2020, Italy).
Academic Article	Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade.
Academic Article	Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund's adjuvant (IFA) for resected high-risk melanoma.
Academic Article	Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf-mutated melanoma.
Academic Article	Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
Academic Article	Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma.
Academic Article	Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary.
Academic Article	LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade.
Academic Article	Perspectives in Immunotherapy: meeting report from the Immunotherapy Bridge, December 1st-2nd, 2021.
Academic Article	Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males.
Academic Article	Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Academic Article	Multi-modal molecular programs regulate melanoma cell state.
Academic Article	Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma.
Academic Article	Correction: IL-1a Mediates Innate and Acquired Resistance to Immunotherapy in Melanoma.

Search Criteria

Melanoma